Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “non-small cell lung cancer”
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT06465329. IPD Sharing: YES. Countries: 6. Publications: 0.
Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00447057. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01809210. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02839265. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS)
ClinicalTrials.gov study NCT01183858. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery
ClinicalTrials.gov study NCT00049543. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT05785767. IPD Sharing: YES. Countries: 11. Publications: 0.
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
ClinicalTrials.gov study NCT03532698. IPD Sharing: UNDECIDED. Countries: 0. Publications: 6.
To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00191191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression
ClinicalTrials.gov study NCT01230710. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
ClinicalTrials.gov study NCT00988169. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients
ClinicalTrials.gov study NCT00350792. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
ClinicalTrials.gov study NCT03634241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04250545. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01494558. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04203485. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03228186. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07249372. IPD Sharing: YES. Countries: 1. Publications: 0.
Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00278148. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
ClinicalTrials.gov study NCT02262325. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.